Skip to main content

Table 6 Types of GI tools within GI tool categories by guideline characteristics

From: Number and type of guideline implementation tools varies by guideline, clinical condition, country of origin, and type of developer organization: content analysis of guidelines

Guideline characteristic (n GI tools)

GI tool categories and types (n, %)

Patient

Clinician

Implementation

Evaluation

Total

Information

Self-management

Guideline summary

Total

Guideline summary

Algorithm

Form or checklist

Total

Training material

Resources

Total

Audit tool

Measures

Overall

113

92 (81.4)

15 (13.3)

6 (5.3)

239

116 (48.5)

92 (38.5)

31 (13.0)

66

37 (56.1)

29 (43.9)

46

30 (65.2)

16 (34.8)

Condition

 Diabetes

37

31 (83.8)

3 (8.1)

3 (8.1)

64

35 (54.7)

18 (28.1)

11 (17.2)

20

12 (60.0)

8 (40.0)

9

6 (66.7)

3 (33.3)

 Stroke

26

23 (88.5)

2 (7.7)

1 (3.8)

63

40 (63.5)

13 (20.6)

10 (15.9)

8

3 (37.5)

5 (62.5)

3

3 (100.0)

0 (0.0)

 Heart failure

15

9 (60.0)

4 (26.7)

2 (13.3)

48

5 (10.4)

43 (89.6)

0 (0.0)

14

8 (57.1)

6 (42.9)

11

7 (63.6)

4 (36.4)

 Asthma

15

10 (66.7)

5 (33.3)

0 (0.0)

30

22 (73.3)

4 (13.3)

4 (13.3)

4

3 (75.0)

1 (25.0)

1

0 (0.0)

1 (100.0)

 Arthritis

12

12 (100.0)

0 (0.0)

0 (0.0)

13

5 (38.5)

8 (61.5)

0 (0.0)

6

1 (16.7)

5 (83.3)

4

2 (50.0)

2 (50.0)

 Depression

5

4 (80.0)

1 (20.0)

0 (0.0)

20

9 (45.0)

5 (25.0)

6 (30.0)

10

8 (80.0)

2 (20.0)

7

2 (28.6)

5 (71.4)

 Colorectal cancer

3

3 (100.0)

0 (0.0)

0 (0.0)

1

0 (0.0)

1 (100.0)

0 (0.0)

4

2 (50.0)

2 (50.0)

11

10 (90.9)

1 (9.1)

COUNTRY

 United States (199)

62

43 (69.4)

13 (21.0)

6 (9.7)

121

58 (47.9)

48 (39.7)

15 (12.4)

16

15 (93.8)

1 (6.3)

0

0 (0.0)

0 (0.0)

 United Kingdom (151)

28

26 (92.9)

2 (7.1)

0 (0.0)

38

6 (15.8)

32 (84.2)

0 (0.0)

41

15 (36.6)

26 (63.4)

44

28 (63.6)

16 (36.4)

 Canada (90)

21

21 (100.0)

0 (0.0)

0 (0.0)

60

43 (71.7)

4 (6.7)

13 (21.7)

8

6 (75.0)

2 (25.0)

1

1 (100.0)

0 (0.0)

 Australia (11)

1

1 (100.0)

0 (0.0)

0 (0.0)

9

5 (55.6)

2 (22.2)

2 (22.2)

0

0 (0.0)

0 (0.0)

1

1 (100.0)

0 (0.0)

 International (8)

1

1 (100.0)

0 (0.0)

0 (0.0)

7

3 (42.9)

4 (57.1)

0 (0.0)

0

0 (0.0)

0 (0.0)

0

0 (0.0)

0 (0.0)

 Singapore (3)

0

0 (0.0)

0 (0.0)

0 (0.0)

2

1 (50.0)

0 (0.0)

1 (50.0)

1

1 (100.0)

0 (0.0)

0

0 (0.0)

0 (0.0)

 Brazil (2)

0

0 (0.0)

0 (0.0)

0 (0.0)

2

0 (0.0)

2 (100.0)

0 (0.0)

0

0 (0.0)

0 (0.0)

0

0 (0.0)

0 (0.0)

 Finland (0)

0

0 (0.0)

0 (0.0)

0 (0.0)

0

0 (0.0)

0 (0.0)

0 (0.0)

0

0 (0.0)

0 (0.0)

0

0 (0.0)

0 (0.0)

 Spain (0)

0

0 (0.0)

0 (0.0)

0 (0.0)

0

0 (0.0)

0 (0.0)

0 (0.0)

0

0 (0.0)

0 (0.0)

0

0 (0.0)

0 (0.0)

Organization

 Government (166)

39

35 (89.7)

3 (7.7)

1 (2.6)

48

12 (25.0)

32 (66.7)

4 (8.3)

40

14 (35.0)

26 (65.0)

39

25 (64.1)

14 (35.9)

 Professional society (135)

23

15 (65.2)

3 (13.0)

5 (21.7)

97

41 (42.3)

48 (49.5)

8 (8.2)

13

11 (84.6)

2 (15.4)

2

1 (50.0)

1 (50.0)

 Disease foundation (66)

18

18 (100.0)

0 (0.0)

0 (0.0)

37

25 (67.6)

3 (8.1)

9 (24.3)

4

3 (75.0)

1 (25.0)

4

3 (75.0)

1 (25.0)

 Academic institution (63)

29

21 (72.4)

8 (27.6)

0 (0.0)

31

21 (67.7)

3 (9.7)

7 (22.6)

6

6 (100.0)

0 (0.0)

0

0 (0.0)

0 (0.0)

 Non-profit agency (33)

4

3 (75.0)

1 (25.0)

0 (0.0)

25

16 (64.0)

6 (24.0)

3 (12.0)

3

3 (100.0)

0 (0.0)

1

1 (100.0)

0 (0.0)

 International group (1)

0

0 (0.0)

0 (0.0)

0 (0.0)

1

1 (100.0)

0 (0.0)

0 (0.0)

0

0 (0.0)

0 (0.0)

0

0 (0.0)

0 (0.0)